EGFR罕見突變在臨床上的分類及治療進展，特別關注第二十外顯子插入基因突變Therapeutic Advances of Uncommon EGFR Mutations

EGFR罕見突變，尤其是第20外顯子的插入基因突變，在臨床上具有特殊分類。這些突變形式對治療提出挑戰，但近期取得了一些新的進展。治療方針需根據具體突變類型制定，以提高療效。

Uncommon EGFR mutations, particularly insertions in the 20th exon, exhibit distinctive classifications in clinical settings. Managing these mutations poses challenges, but recent advancements bring new hope. Tailored treatment strategies based on specific mutation types are pivotal for enhancing therapeutic efficacy.